Catalyst Wire Dossier Catalyst Wire Dossier

Stocrin

efavirenz · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Stocrin, covering 2015-07-21 to 2026-07-01. Get the full timeline:

Most recent: EMA Withdrawn: Stocrin (efavirenz) — Merck Sharp & Dohme B.V.

See pricing